An elaborate pathway required for Ras-mediated epigenetic silencing

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Cancer development involves oncogene activation and tumor suppressor gene inactivation.
• Epigenetic silencing, particularly DNA hypermethylation, is a key mechanism for gene inactivation in cancer.
• The specific pathways by which oncogenes initiate epigenetic silencing remain largely undefined.

Purpose of the Study:

• To identify genes involved in Ras-mediated epigenetic silencing of the pro-apoptotic Fas gene.
• To elucidate the pathway through which Ras oncogenes induce epigenetic silencing.
• To determine if these silencing pathways are essential for cancer cell transformation and tumorigenicity.

Main Methods:

• Genome-wide RNA interference (RNAi) screen in K-ras-transformed NIH 3T3 cells.
• Identification and characterization of Ras epigenetic silencing effectors (RESEs).
• Analysis of gene recruitment to promoter regions, DNA methylation status, and gene expression levels.

Main Results:

• Identified 28 genes (RESEs) required for Ras-mediated epigenetic silencing of the Fas gene.
• Demonstrated that RESEs, including DNMT1, are recruited to the Fas promoter in transformed cells.
• Showed that knockdown of RESEs leads to loss of Fas promoter hypermethylation and derepression of Fas expression.
• Found that Ras utilizes a common pathway for silencing multiple genes.
• Confirmed that nine RESEs are essential for anchorage-independent growth and tumorigenicity.

Conclusions:

• Ras oncogene-mediated epigenetic silencing is a specific, complex process involving a defined pathway.
• This pathway, utilizing RESEs, is critical for maintaining the transformed phenotype and tumorigenicity.
• Identified novel genes implicated in Ras-driven cancer development.